A safe, simple and efficient doxorubicin prodrug hybrid micelle for overcoming tumor multidrug resistance and targeting delivery

TPGS-CHN-DOX prodrug hybrid micelles were developed with synergistic effect of pH-triggered burst release behavior and additional bioactivity of drug carrier to overcome MDR and inhibit the potential metastasis of tumor.184